| Following are a
few examples of how CTG has created exceptional value for its
- ev3, Inc. has retained
CTG since 2002 to establish, ramp-up, and manage their
Japanese subsidiary, and recently to downsize the sales
and marketing division following the appointment of Nihon
Medtronic as sole distributor for the products in Japan.
- Aksys, Ltd., called
on CTG to help develop a strategy for bringing its hemodialysis
products to Japan, the world's largest hemodialysis market.
CTG identified several potential partners in Japan, and
eventually helped Aksys complete a series of multi-million
dollar contracts with Teijin, the leading homecare company
in Japan. The contracts generated total cash payments
to Aksys of more than $20 million.
- ResMed asked CTG
to assess the Japanese market for its products and to suggest
strategies to improve marketing and sales. By the end of
CTG's year-long involvement, ResMed’s annual sales
to Japan had grown by approximately 50%. Further, ResMed's
Japanese importer and distributor both expanded and accelerated
the nation-wide rollout of sleep centers that feature ResMed's
sleep apnea products.
- Following the failure of its relationship
with Nihon Medtronic, Pharma-Sept,
Ltd., an Israeli manufacturer
of specialty plastic drapes for the OR, began distributing
its products through CTG. Starting from zero, Pharma-Sept's
line of HLT microscope covers have grown in less than
3 years to more than 10% market share nationwide and
are now used by neurosurgeons, ENT, and orthopedic surgeons
in >200 hospitals including more than one-third of
the 80 university hospitals.
- When MediSense
fired the president of its Japanese subsidiary, it retained
CTG to take over management duties. CTG turned the business
cash-flow positive and ramped revenues from $4 million to
$10 million annually. CTG continued to manage the business
for several years.
When your plans include the Japanese
market, call on CTG for the experience you need. Contact
us to discuss how we may be able to help you in Japan.